Marketing-authorisation holder · Singapore
Abbvie Pte. Ltd.
45 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · Singapore
45 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 45
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ACULAR OPHTHALMIC SOLUTION 0.5%0.5% w/v · Solution | Ketorolac | Singapore | Authorised | 1999 |
| ALPHAGAN OPHTHALMIC SOLUTION 0.2%0.20% · Solution | Brimonidine | Singapore | Authorised | 1998 |
| ALPHAGAN P OPHTHALMIC SOLUTION 0.1% w/v0.1% w/v · Solution, sterile | Brimonidine | Singapore | Authorised | 2025 |
| ALPHAGAN P OPHTHALMIC SOLUTION 0.15% w/v0.15% w/v · Solution | Brimonidine | Singapore | Authorised | 2003 |
| AQUIPTA TABLET 10MG10.0mg · Tablet | Atogepant | Singapore | Authorised | 2024 |
| AQUIPTA TABLET 60MG60.0mg · Tablet | Atogepant | Singapore | Authorised | 2024 |
| BOTOX POWDER FOR SOLUTION FOR INJECTION 100 Units/Vial100 units/vial · Injection, powder, for solution | Botulinum toxin | Singapore | Authorised | 1995 |
| Botox® Powder for Solution for Injection 200 Units/Vial200 Units · Injection, powder, for solution | Botulinum toxin | Singapore | Authorised | 2012 |
| Botox® Powder for Solution for Injection 50 Units/Vial50 Units · Injection, powder, for solution | Botulinum toxin | Singapore | Authorised | 2012 |
| COMBIGAN®2.0 mg/ml + 5 mg/ml · Solution, sterile | Brimonidine, Timolol | Singapore | Authorised | 2008 |
| ELAHERE CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/20ML100mg/20mL · Infusion, solution concentrate | Mirvetuximab soravtansine | Singapore | Authorised | 2025 |
| EPKINLY SOLUTION FOR INJECTION 48MG/0.8ML48mg/0.8mL · Injection, solution | Epcoritamab | Singapore | Authorised | 2024 |
| EPKINLY SOLUTION FOR INJECTION 4MG/0.8ML4.0mg/0.8mL · Injection, solution, concentrate | Epcoritamab | Singapore | Authorised | 2024 |
| FML LIQUIFILM OPHTHALMIC SUSPENSION 0.1%0.1% w/v · Solution | Fluorometholone | Singapore | Authorised | 1990 |
| Ganfort Eye Drops0.3mg/ml + 5mg/ml · Solution, sterile | Bimatoprost, Timolol | Singapore | Authorised | 2008 |
| GANFORT PF EYE DROPS (Bimatoprost 0.3mg/ml, Timolol 5.0mg/ml)0.3 mg/ml + 5 mg/ml · Solution, sterile | Bimatoprost, Timolol | Singapore | Authorised | 2016 |
| HUMIRA SOLUTION FOR INJECTION 20MG/0.2ML (PRE-FILLED SYRINGE)20.0mg/0.2mL · Injection, solution | Adalimumab | Singapore | Authorised | 2019 |
| HUMIRA SOLUTION FOR INJECTION 40MG/0.4ML (PRE-FILLED PEN)40.0 mg · Injection, solution | Adalimumab | Singapore | Authorised | 2017 |
| HUMIRA SOLUTION FOR INJECTION 40MG/0.4ML (PRE-FILLED SYRINGE)40mg/0.4ml · Injection, solution | Adalimumab | Singapore | Authorised | 2019 |
| HUMIRA SOLUTION FOR INJECTION 80MG/0.8ML (PREFILLED PEN)80.0mg/0.8mL · Injection, solution | Adalimumab | Singapore | Authorised | 2020 |
| HUMIRA SOLUTION FOR INJECTION 80MG/0.8ML (PREFILLED SYRINGE)80.0mg/0.8mL · Injection, solution | Adalimumab | Singapore | Authorised | 2020 |
| KALETRA ORAL SOLUTION80 mg + 20 mg · Syrup | Lopinavir, Ritonavir | Singapore | Authorised | 2001 |
| Kaletra Tablet 200mg/50mg200.0mg + 50.0mg · Tablet, film coated | Lopinavir, Ritonavir | Singapore | Authorised | 2007 |
| Lucrin Depot for Injection PDS 11.25mg11.25mg · Injection, powder, for solution | Leuprorelin | Singapore | Authorised | 1999 |
| Lucrin Depot for Injection PDS 3.75mg3.75mg · Injection, powder, for solution | Leuprorelin | Singapore | Authorised | 1996 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Singapore | 45 | 45 | 0 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.